Univest
Univest
  • Markets

Themis Medicare vs Nifty 50: Returns Compared

  • October 13, 2026
  • Posted by: Kunal Singla
  • Category: Market
No Comments
Themis Medicare vs Nifty 50: Returns Compared

Themis Medicare share price Rs 107.02 on NSE. Themis Medicare vs Nifty 50 over 1 year: -16.19% vs -11.35%. 52-week high Rs 140.60, low Rs 64.95.

Quick Answer

Themis Medicare vs Nifty 50 gives a mixed picture: Themis Medicare has beaten the index in 1 of 5 time frames, and its 1-year return of -16.19% compares with -11.35% for the Nifty 50. Over three years, Themis Medicare fell 36.84% while the Nifty 50 gained 13.23%, a gap of 50.07 percentage points against it. At Rs 107.02, Themis Medicare is 23.9% below its 52-week high of Rs 140.60 and 64.8% above its 52-week low of Rs 64.95. Returns use NSE closing prices to 12 October 2026, and past performance does not indicate future results.

Themis Medicare vs Nifty 50 is a comparison that looks different depending on the time frame chosen. Themis Medicare trades on the NSE under the symbol THEMISMED, and its 1-month return of -16.55% compares with -4.42% for the Nifty 50 over the same period.

The Themis Medicare vs Nifty 50 comparison matters because Themis Medicare is a single stock exposed to its own business and sector developments, while the Nifty 50 spreads risk across 50 large companies. This article lines up Themis Medicare share price performance against the Nifty 50 across 1 month, 3 months, 6 months, 1 year and 3 years, using NSE closing data up to 12 October 2026.

Also read – Bombay Burmah Trading Corporation vs Nifty 50: Returns Compared

Click Here – Get Free Investment Predictions

Table of Contents

Toggle
  • Themis Medicare vs Nifty 50: Performance at a Glance
  • Latest Close and 52-Week Range: Themis Medicare and the Nifty 50
  • Why the Themis Medicare vs Nifty 50 Gap Exists
  • Themis Medicare vs Nifty 50: Has Themis Medicare Beaten the Benchmark?
  • Risks of the Themis Medicare vs Nifty 50 Comparison
  • Conclusion
    • Has Themis Medicare outperformed the Nifty 50 in the last year?
    • How does Themis Medicare vs Nifty 50 look over 3 years?
    • What is the Themis Medicare share price today compared to Nifty 50?
    • What is the 52-week high and low of Themis Medicare?
    • Why does Themis Medicare show bigger price swings than the Nifty 50?
    • Is Themis Medicare a good long-term investment compared to a Nifty 50 index fund?

Themis Medicare vs Nifty 50: Performance at a Glance

The table below sets out the Themis Medicare vs Nifty 50 performance across the available time frames, measured from NSE closing prices up to 12 October 2026.

Time Frame Themis Medicare Return Nifty 50 Return Difference
1 Month -16.55% -4.42% -12.13 pp
3 Months -7.88% -7.63% -0.25 pp
6 Months +30.34% -6.20% +36.54 pp
1 Year -16.19% -11.35% -4.84 pp
3 Years -36.84% +13.23% -50.07 pp

On the Themis Medicare vs Nifty 50 scorecard, Themis Medicare has trailed the index over the latest 1-year window, returning -16.19% against -11.35% for the Nifty 50, a difference of 4.84 percentage points. The widest gap on the table is over three years, where Themis Medicare fell 36.84% while the Nifty 50 gained 13.23%, a difference of 50.07 percentage points against the stock. Both Themis Medicare and the index lost ground over the past year, so the comparison here is about which of the two lost less.

Check the Univest Screener for live Themis Medicare and Nifty 50 data

Latest Close and 52-Week Range: Themis Medicare and the Nifty 50

Instrument Latest Close 52-Week High 52-Week Low Vs 52-Week High
Themis Medicare Rs 107.02 Rs 140.60 Rs 64.95 -23.9%
Nifty 50 22,363.35 26,373.20 22,179.90 -15.2%

Themis Medicare closed at Rs 107.02 on 12 October 2026, which is 23.9% below its 52-week high of Rs 140.60 and 64.8% above its 52-week low of Rs 64.95. The Nifty 50 closed at 22,363.35, 15.2% below its own 52-week high of 26,373.20, so the benchmark has also been through a drawdown over the past year.

Why the Themis Medicare vs Nifty 50 Gap Exists

Themis Medicare can move very differently from the Nifty 50 because it carries concentrated exposure to its own business and sector cycle, while the index blends 50 companies across banking, IT, energy and consumer sectors. The 52-week range shows it clearly: Themis Medicare has traded between Rs 64.95 and Rs 140.60, a spread of 116.5% from low to high, against 18.9% for the Nifty 50.

Trading depth also shapes the Themis Medicare vs Nifty 50 gap. Stocks with a smaller trading base tend to react more to a single result, block deal or news item than the diversified Nifty 50 does, and Themis Medicare is judged on its own record rather than on an average.

Download the Univest iOS App or Univest Android App to track Themis Medicare and Nifty 50 live on the go.

Themis Medicare vs Nifty 50: Has Themis Medicare Beaten the Benchmark?

No, not over the past year. Themis Medicare returned -16.19% against -11.35% for the Nifty 50, a shortfall of 4.84 percentage points. Across the five time frames measured, Themis Medicare is ahead of the index over 6 months and behind it over 1 month, 3 months, 1 year and 3 years.

Risks of the Themis Medicare vs Nifty 50 Comparison

Point-to-point returns can mislead, and the Themis Medicare vs Nifty 50 comparison is no exception. A different start date would shift every figure in the table above, and past performance does not indicate how either Themis Medicare or the Nifty 50 will perform from here.

Also read – TVS Holdings vs Nifty 50: Returns Compared

Themis Medicare carries concentrated business and sector risk that a diversified index does not. Its 52-week range of Rs 64.95 to Rs 140.60 shows the scale of the swings a single-stock investor has lived with, against a range of 22,179.90 to 26,373.20 for the Nifty 50.

Conclusion

Themis Medicare vs Nifty 50 shows Themis Medicare ahead of the index in 1 of 5 time frames and behind in the rest, which is why the answer depends on the horizon an investor cares about. Volatility, liquidity and sector concentration deserve as much weight as the return history, and a SEBI-registered advisor can help fit Themis Medicare into a wider portfolio.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

Has Themis Medicare outperformed the Nifty 50 in the last year?

Ans. No. Themis Medicare returned -16.19% over the past year while the Nifty 50 returned -11.35%, based on NSE closing prices to 12 October 2026.

How does Themis Medicare vs Nifty 50 look over 3 years?

Ans. Over three years Themis Medicare has returned -36.84% compared with the Nifty 50’s +13.23%, so in the Themis Medicare vs Nifty 50 comparison the stock has been behind over this horizon.

What is the Themis Medicare share price today compared to Nifty 50?

Ans. Themis Medicare share price closed at Rs 107.02 on NSE on 12 October 2026, while the Nifty 50 closed at 22,363.35 in the same session.

What is the 52-week high and low of Themis Medicare?

Ans. Themis Medicare’s 52-week high is Rs 140.60 and its 52-week low is Rs 64.95, based on NSE data. The latest close of Rs 107.02 is 23.9% below the high.

Why does Themis Medicare show bigger price swings than the Nifty 50?

Ans. Themis Medicare carries concentrated exposure to its own sector and business cycle, while the Nifty 50 spreads risk across 50 large companies. Over 52 weeks Themis Medicare has traded in a 116.5% low-to-high range against 18.9% for the index, a key reason the Themis Medicare vs Nifty 50 return gap varies across time frames.

Is Themis Medicare a good long-term investment compared to a Nifty 50 index fund?

Ans. Themis Medicare’s suitability depends on an investor’s risk appetite, since single-stock exposure carries higher concentration risk than a diversified Nifty 50 index fund. Long-term investors should weigh the Themis Medicare vs Nifty 50 return history alongside the company’s fundamentals and consult a SEBI-registered advisor.



Nifty 50 Stock Market
Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply